Concepedia

P. Erbel

PE

29

Publications

2.3K

Citations

25

H-Index

1999

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

The University of Texas Southwestern Medical Center

Utrecht University

Novartis (United States)

P. Erbel is an author at Novartis (Switzerland) specializing in medicine, biochemistry, and natural sciences.

ORCID

Top concepts

Publications per year

1999–2021

29

Publications

29

Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus

P. Erbel, Nikolaus Schiering, A. D’Arcy et al. · Nature Structural & Molecular Biology · 2006 · 567 citations

, , +10

Structural basis for PAS domain heterodimerization in the basic helix–loop–helix-PAS transcription factor hypoxia-inducible factor

P. Erbel, Paul B. Card, Ozgur Karakuzu et al. · Proceedings of the National Academy of Sciences · 2003 · 226 citations · Full text

Small-molecule factor B inhibitor for the treatment of complement-mediated diseases

Anna Schubart, Karen Anderson, Nello Mainolfi et al. · Proceedings of the National Academy of Sciences · 2019 · 206 citations · Full text

, , +23

Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition

Carien Dekker, Henri Mattes, Michael Wright et al. · Journal of Molecular Biology · 2021 · 149 citations

, , +9

Structural Basis of ARNT PAS-B Dimerization: Use of a Common Beta-sheet Interface for Hetero- and Homodimerization

Paul B. Card, P. Erbel, Kevin H. Gardner · Journal of Molecular Biology · 2005 · 142 citations

, , +10

Rows per page

1–5 of 29